Ischemic stroke is a major cause of death and disability, and no neuroprotective therapy is available. Thus, our consortium aims to develop the first pharmaceutical for ischemic strokes that reduces neuronal cell death, improves the wellbeing of patients and lowers the economic burden of societies.
Participating countries >THE NETHERLANDS,SWEDEN (bron: www.eurekanetwork.org/project-search)
